Publisher： Bentham Science Publishers
E-ISSN： 1873-5592|19|1|55-69
ISSN： 1389-4501
Source： Current Drug Targets, Vol.19, Iss.1, 2018-01, pp. : 55-69
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 17, Iss. 1, 2017-06 ,pp. :
Orlistat: In the Prevention and Treatment of Type 2 Diabetes Mellitus
Drugs, Vol. 61, Iss. 14, 2001-01 ,pp. :
Meglitinide Analogues in the Treatment of Type 2 Diabetes Mellitus
By Landgraf R.
Drugs & Aging, Vol. 17, Iss. 5, 2000-11 ,pp. :
Orlistat in the treatment of Type 2 diabetes mellitus
Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 5, 2002-05 ,pp. :